Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,708.24
(
1.15%
)
US TECH 100
24,046.40
(
1.25%
)
Dow Jones
46,986.33
(
0.92%
)
Brent Oil
98.17
(
-3.03%
)
Bitcoin
74,173.63
(
1.87%
)
News Focus
News Focus

Replies to post #254953 on Biotech Values

Replies to #254953 on Biotech Values
icon url

DewDiligence

04/01/25 2:39 PM

#254954 RE: Whalatane #254953

Drug approvals risk being delayed…

FDA reviews cannot be delayed much, if at all, without breaching the minimum performance metrics inherent in Congress’ PDUFA funding for these reviews.